Blocking integrin ligands or inhibiting downstream FAK/PYK2 signaling not only reduced T-ALL burden across multiple organs, including the BM, but also prolonged survival of leukemic mice43. This evidence concerns the gene PTK2 and acute lymphoblastic leukemia.